Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway
Stephanie M. Todd, Cilla Zhou, David J. Clarke, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 2, pp. 132-145
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
María S. García‐Gutiérrez, Francisco Navarrete, Ani Gasparyan, et al.
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1575-1575
Open Access | Times Cited: 211
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Emilio Perucca
Journal of Epilepsy Research (2017) Vol. 7, Iss. 2, pp. 61-76
Open Access | Times Cited: 209
Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC
Tomáš Hložek, Libor Uttl, L. Kadeřábek, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 12, pp. 1223-1237
Closed Access | Times Cited: 207
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
Nadia Solowij, Samantha J. Broyd, Lisa‐Marie Greenwood, et al.
European Archives of Psychiatry and Clinical Neuroscience (2019) Vol. 269, Iss. 1, pp. 17-35
Open Access | Times Cited: 161
Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy
Valentina Franco, Emilio Perucca
Drugs (2019) Vol. 79, Iss. 13, pp. 1435-1454
Closed Access | Times Cited: 148
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
Philippe A. Melas, María Scherma, Walter Fratta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1863-1863
Open Access | Times Cited: 98
Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review
Premalatha Balachandran, Mahmoud A. ElSohly, Kevin P. Hill
Journal of General Internal Medicine (2021) Vol. 36, Iss. 7, pp. 2074-2084
Open Access | Times Cited: 81
Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats
Erin M. Rock, Cheryl L. Limebeer, Gavin N. Petrie, et al.
Psychopharmacology (2017) Vol. 234, Iss. 14, pp. 2207-2217
Closed Access | Times Cited: 65
Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Actions of Phytocannabinoids or Endocannabinoids on TRPA1 and TRPV1 Channels
Marika Heblinski, Marina Santiago, Charlotte Fletcher, et al.
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 4, pp. 305-317
Open Access | Times Cited: 46
Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis
C. Kwee, N.A. Leen, Rian C. Van der Kamp, et al.
European Neuropsychopharmacology (2023) Vol. 72, pp. 79-94
Open Access | Times Cited: 16
Epigenetic effects of cannabis: A systematic scoping review of behavioral and emotional symptoms associated with cannabis use and exocannabinoid exposure
Ana Sofia Machado, Miguel Bragança, Maria Augusta Vieira‐Coelho
Drug and Alcohol Dependence (2024) Vol. 263, pp. 111401-111401
Open Access | Times Cited: 4
Analysis of the Uptake, Metabolism, and Behavioral Effects of Cannabinoids on Zebrafish Larvae
John C. Achenbach, Jessica Nixon, Joseph P. M. Hui, et al.
Zebrafish (2018) Vol. 15, Iss. 4, pp. 349-360
Open Access | Times Cited: 37
Comparison of cannabinoids with known analgesics using a novel high throughput zebrafish larval model of nociception
Lee Ellis, Fabrice Berrué, Michael G. Morash, et al.
Behavioural Brain Research (2017) Vol. 337, pp. 151-159
Open Access | Times Cited: 34
Cannabidiol in clinical and preclinical anxiety research. A systematic review into concentration–effect relations using the IB-de-risk tool
C. Kwee, Joop MA van Gerven, Fleur L.P. Bongaerts, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 12, pp. 1299-1314
Open Access | Times Cited: 17
Molecular Insights into Epigenetics and Cannabinoid Receptors
Balapal S. Basavarajappa, Shivakumar Subbanna
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1560-1560
Open Access | Times Cited: 15
Endocannabinoid signaling and epigenetics modifications in the neurobiology of stress-related disorders
Arthur Alves Coelho, Sávio Lima-Bastos, Pedro H. Gobira, et al.
Neuronal Signaling (2023) Vol. 7, Iss. 2
Open Access | Times Cited: 8
Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol
Nicholas Z. Greene, Jenny L. Wiley, Zhihao Yu, et al.
Psychopharmacology (2018) Vol. 235, Iss. 11, pp. 3289-3302
Open Access | Times Cited: 26
Adolescent behavioral abnormalities in a Scn1a+/− mouse model of Dravet syndrome
Dilara Bahceci, Lyndsey L. Anderson, C. Brown, et al.
Epilepsy & Behavior (2019) Vol. 103, pp. 106842-106842
Closed Access | Times Cited: 25
Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
Luísa Rocha, Christian Lizette Frías‐Soria, José G. Ortíz, et al.
Epilepsia Open (2020) Vol. 5, Iss. 1, pp. 36-49
Open Access | Times Cited: 23
The molecular hallmarks of epigenetic effects mediated by antiepileptic drugs
Víctor Navarrete-Modesto, Sandra Orozco‐Suárez, Iris A. Feria-Romero, et al.
Epilepsy Research (2018) Vol. 149, pp. 53-65
Closed Access | Times Cited: 21
Reelin deficiency contributes to long-term behavioral abnormalities induced by chronic adolescent exposure to Δ9-tetrahydrocannabinol in mice
Attilio Iemolo, Patricia Montilla‐Perez, Jacques D. Nguyen, et al.
Neuropharmacology (2021) Vol. 187, pp. 108495-108495
Open Access | Times Cited: 17
Translational models of cannabinoid vapor exposure in laboratory animals
Catherine F. Moore, Jeffrey W. Stiltner, Catherine M. Davis, et al.
Behavioural Pharmacology (2020) Vol. 33, Iss. 2&3, pp. 63-89
Open Access | Times Cited: 17
Phytocannabinoids in neuromodulation: From omics to epigenetics
Subhadip Banerjee, Debolina Saha, Rohit Sharma, et al.
Journal of Ethnopharmacology (2024) Vol. 330, pp. 118201-118201
Closed Access | Times Cited: 1
Epigenetic mechanisms associated with addiction-related behavioural effects of nicotine and/or cocaine: implication of the endocannabinoid system
Tamaki Hayase
Behavioural Pharmacology (2017) Vol. 28, Iss. 7, pp. 493-511
Closed Access | Times Cited: 11
Cross state-dependency of learning between arachidonylcyclopropylamide (ACPA) and muscimol in the mouse dorsal hippocampus
Majid Jafari‐Sabet, Amir-Mohammad Karimi
Pharmacology Biochemistry and Behavior (2017) Vol. 163, pp. 66-73
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top